Big Cypress (BCYP) to Combine with SAB Biotherapeutics in $325M Deal

Big Cypress Acquisition Corp. (NASDAQ:BCYP) has entered into a definitive agreement to combine with clinical-stage biopharmaceutical company SAB Biotherapeutics at an enterprise value of $325 million. Sioux Falls-based SAB Biotherapeutics utilizes advanced genetic engineering and antibody science to develop antibodies that target specific diseases, such as COVID-19. The company’s platform rapidly produces natural, high-potency, human
Read More